Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |